Literature DB >> 8982502

A possible structural determinant of selectivity of boldine and derivatives for the alpha 1A-adrenoceptor subtype.

Y Madrero1, M Elorriaga, S Martinez, M A Noguera, B K Cassels, P D'Ocon, M D Ivorra.   

Abstract

1. The selectivity of action of boldine and the related aporphine alkaloids, predicentrine (9-O-methylboldine) and glaucine (2,9-O-dimethylboldine) and alpha 1-adrenoceptor subtypes was studied by examining [3H]-prazosin competition binding in rat cerebral cortex. WB 4101 and benoxathian were used as selective alpha 1A-adrenoceptor antagonists. 2. In the competition experiments [3H]-prazosin (0.2 nM) binding was inhibited by WB 4101 and benoxathian. The inhibition curves displayed shallow slopes which could be subdivided into high and low affinity components (pKi = 9.92 and 8.29 for WB 4101, 9.35 and 7.94 for benoxathian). The two antagonists recognized approximately 37% of the sites with high affinity from among the total [3H]-prazosin specific binding sites. 3. Boldine, predicentrine and glaucine also competed for [3H]-prazosin (0.2 nM) binding with shallow and biphasic curves recognizing 30-40% of the sites with high affinity. Drug affinities (pKi) at the high and low affinity sites were, 8.31 and 6.50, respectively, for boldine, 8.13 and 6.39 for predicentrine, and 7.12 and 5.92 for glaucine. The relative order of selectivity for alpha 1A-adrenoceptors was boldine (70 fold alpha 1A-selective) = predicentrine (60 fold, alpha 1A-selective) > glaucine (15 fold, alpha 1A-selective). 4. Pretreatment of rat cerebral cortex membranes with chloroethylclonidine (CEC, 10 microM) for 30 min at 37 degrees C followed by thorough washing out reduced specific [3H]-prazosin binding by approximately 70%. The CEC-insensitive [3H]-prazosin binding was inhibited by boldine monophasically (Hill slope = 0.93) with a single pKi value (7.76). 5. These results suggest that whereas the aporphine structure shared by these alkaloids is responsible for their selectively of action for the alpha 1A-adrenoceptor subtype in rat cerebral cortex, defined functional groups, namely the 2-hydroxy function, induces a significant increase in alpha 1A-subtype selectivity and affinity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8982502      PMCID: PMC1915787          DOI: 10.1111/j.1476-5381.1996.tb16073.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  47 in total

1.  Molecular cloning and expression of the cDNA for a novel alpha 1-adrenergic receptor subtype.

Authors:  D A Schwinn; J W Lomasney; W Lorenz; P J Szklut; R T Fremeau; T L Yang-Feng; M G Caron; R J Lefkowitz; S Cotecchia
Journal:  J Biol Chem       Date:  1990-05-15       Impact factor: 5.157

Review 2.  Mechanisms of action of transmitters and other substances on smooth muscle.

Authors:  T B Bolton
Journal:  Physiol Rev       Date:  1979-07       Impact factor: 37.312

3.  Alpha 1-adrenoceptors: the ability of various agonists and antagonists to discriminate between two distinct [3H]prazosin binding sites.

Authors:  G Hanft; G Gross; J J Beckeringh; C Korstanje
Journal:  J Pharm Pharmacol       Date:  1989-10       Impact factor: 3.765

4.  Cyclic nucleotide phosphodiesterase inhibition and vascular smooth muscle relaxation.

Authors:  C Lugnier; Y Bertrand; J C Stoclet
Journal:  Eur J Pharmacol       Date:  1972-07       Impact factor: 4.432

5.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

6.  Antioxidant properties of the alkaloid boldine in systems undergoing lipid peroxidation and enzyme inactivation.

Authors:  H Speisky; B K Cassels; E A Lissi; L A Videla
Journal:  Biochem Pharmacol       Date:  1991-06-01       Impact factor: 5.858

7.  Characterization of alpha 1-adrenergic receptor subtypes in rat brain: a reevaluation of [3H]WB4104 and [3H]prazosin binding.

Authors:  A L Morrow; I Creese
Journal:  Mol Pharmacol       Date:  1986-04       Impact factor: 4.436

8.  Molecular cloning and expression of the cDNA for the alpha 1A-adrenergic receptor. The gene for which is located on human chromosome 5.

Authors:  J W Lomasney; S Cotecchia; W Lorenz; W Y Leung; D A Schwinn; T L Yang-Feng; M Brownstein; R J Lefkowitz; M G Caron
Journal:  J Biol Chem       Date:  1991-04-05       Impact factor: 5.157

9.  Spasmolytic activity of cinnamedrine and papaverine in isolated rat uterine muscle.

Authors:  W R Cumiskey; M E Feigenson
Journal:  Arch Int Pharmacodyn Ther       Date:  1983-05

10.  Effect of papaverine on the frequency-force relationship in guinea-pig left atria.

Authors:  D Reinhardt; W Roggenbach; U Schmidt; H J Schümann
Journal:  Eur J Pharmacol       Date:  1977-01-21       Impact factor: 4.432

View more
  1 in total

1.  Modelling of adrenoceptor ligand targets based on novel medium- or macro-sized fused nitrogen heterocyclic systems.

Authors:  R Griffith; J B Bremner
Journal:  J Comput Aided Mol Des       Date:  1999-01       Impact factor: 3.686

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.